Compile Data Set for Download or QSAR
Report error Found 30 Enz. Inhib. hit(s) with all data for entry = 13093
TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757614(US12358901, Example RE11)
Affinity DataEC50:  794nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757616(US12358901, Example RE13)
Affinity DataEC50:  794nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757608(US12358901, Example 9)
Affinity DataEC50:  1.26E+3nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757608(US12358901, Example 9)
Affinity DataEC50:  1.32E+3nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757604((5R)-5-ethyl-5- methyl-3-[5-(7- methylspiro[2H- be...)
Affinity DataEC50:  2.04E+3nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757609((5R)-5-ethyl-3-(5- spiro[2H- benzofuran-3,1'- cycl...)
Affinity DataEC50:  2.34E+3nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757615(US12358901, Example RE12)
Affinity DataEC50:  2.51E+3nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757595(US12358901, Example RE6)
Affinity DataEC50:  2.63E+3nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757596(US12358901, Example RE7)
Affinity DataEC50:  2.75E+3nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757611((5R)-5-ethyl-3-[5- [(3,3,7-trimethyl- 2H-benzofura...)
Affinity DataEC50:  2.75E+3nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757613(6-[5-(7- methylspiro[2H- benzofuran-3,1'- cyclopro...)
Affinity DataEC50:  3.09E+3nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757600(US12358901, Example 1)
Affinity DataEC50:  3.39E+3nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757609((5R)-5-ethyl-3-(5- spiro[2H- benzofuran-3,1'- cycl...)
Affinity DataEC50:  3.55E+3nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757607((5R)-5-ethyl-5- methyl-3-[5- [(3,3,7-trimethyl- 2H...)
Affinity DataEC50:  5.13E+3nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757591(US12358901, Example RE2)
Affinity DataEC50:  5.62E+3nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757617(US12358901, Example RE14)
Affinity DataEC50:  6.31E+3nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757603(5,5-dimethyl-3- (5-spiro[2H- benzofuran-3,1'- cycl...)
Affinity DataEC50:  6.76E+3nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757602((5R)-5-ethyl-5- methyl-3-(5- spiro[2H- benzofuran-...)
Affinity DataEC50:  7.08E+3nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757594(US12358901, Example RE5)
Affinity DataEC50:  7.24E+3nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757606(5,5-dimethyl-3- [5-[(3,3,7- trimethyl-2H- benzofur...)
Affinity DataEC50:  7.59E+3nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757612(7-[5-(7- methylspiro[2H- benzofuran-3,1'- cyclopro...)
Affinity DataEC50:  8.13E+3nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757597(US12358901, Example RE8)
Affinity DataEC50:  1.05E+4nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757610((5R)-3-[5-[(3,3- dimethyl-2H- benzofuran-4- yl)oxy...)
Affinity DataEC50:  1.29E+4nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757592(US12358901, Example RE3)
Affinity DataEC50:  1.29E+4nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757590(US12358901, Example RE1)
Affinity DataEC50:  1.66E+4nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757605((5R)-3-[5-[(3,3- dimethyl-2H- benzofuran-4- yl)oxy...)
Affinity DataEC50:  1.78E+4nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757601(3-[5-[(3,3- dimethyl-2H- benzofuran-4- yl)oxy]pyra...)
Affinity DataEC50:  2.09E+4nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757598(US12358901, Example RE9)
Affinity DataEC50: >5.01E+4nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757599(US12358901, Example RE10)
Affinity DataEC50: >5.01E+4nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent

TargetPotassium voltage-gated channel subfamily C member 1(Human)
Autifony Therapeutics

US Patent
LigandPNGBDBM757593(US12358901, Example RE4)
Affinity DataEC50: >5.01E+4nMAssay Description:Experiments are conducted at r.t. using IonWorks Quattro™ planar array electrophysiology technology (Molecular Devices Corp.) with PatchPlate™ PPC. S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/28/2025
Entry Details
US Patent